This presentation addresses the financial and regulatory challenges facing developers of biosolids treatment technologies and outlines a technology developer's experience with EPA’s Pathogen Equivalency Committee process. It was presented at the Cluster Leaders Meeting on March 25, 2014 by Dr. Fred Musari of BCR Environmental Corporation.
You will need Adobe Reader to view some of the files on this page. See EPA’s About PDF page to learn more.- BCR Environmental (PDF)(11 pp, 1 MB)